Needham & Company LLC Reaffirms Buy Rating for Vaxcyte (NASDAQ:PCVX)
Vaxcyte (NASDAQ:PCVX – Get Free Report)‘s stock had its “buy” rating restated by investment analysts at Needham & Company LLC in a note issued to investors on Wednesday, Benzinga reports. They presently have a $58.00 price target on the stock. Needham & Company LLC’s target price would suggest a potential upside of 22.80% from the […]